Sonoma Pharmaceuticals (Formerly Oculus Innovative Sciences) is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Active Ingredient: Microdacyn.
Microdacyn for irrigation and debridement to significantly improve Wound Healing
Active Ingredient: Advanced dermatological gel containing MicroHeal technology to control dermatitis
BabySoothe is an adjuvant in the wound healing process for the treatment of Atopic Dermatitis, including Eczema, Nappy Rash and Dermatitis.
Active Ingredient: MicroHeal containing dermatological cleanser and anti-acne hydrogel
For the adjunct management of mild to moderate acne.